The European Adult Immunisation Hub is led by the International Longevity Centre – UK (ILC-UK). It has been made possible by financial support from Pfizer.
For regular updates, follow the European Adult Immunisation Hub on Twitter at @AImmunisation,
like the Hub’s Facebook page at https://www.facebook.com/adultimmunisation/timeline
and join the Adult Immunisation Linkedin group at https://www.linkedin.com/groups/8358969
The UK’s National Institute for Health Research produces new infographic demonstrating the cost effectiveness of immunisation.
The Sydney Morning Herald has posted an interesting comment piece about low vaccination rates among adults, highlighting some of the benefits and barriers to, vaccinating adults.
New research reported in the Daily Mail finds that “vaccine-preventable diseases among adults cost the U.S. economy $8.95 billion in 2015”. The Daily Mail reports that Eighty per cent of this spending was used to treat unvaccinated individuals. They highlight that flu, pneumococcal disease and shingles pose the biggest cost to healt
In one of only four times the a UN declaration has been reached on a health issue, landmark agreement reached to tackle antimicrobial resistance.
Following Hillary Clinton’s diagnosis of pneumonia, global public attention in the disease has increased dramatically. But what is pneumonia, and how can it be prevented?